ID KCNJ9_HUMAN Reviewed; 393 AA. AC Q92806; Q5JW75; DT 01-NOV-1997, integrated into UniProtKB/Swiss-Prot. DT 06-FEB-2007, sequence version 2. DT 24-JAN-2024, entry version 191. DE RecName: Full=G protein-activated inward rectifier potassium channel 3; DE Short=GIRK-3; DE AltName: Full=Inward rectifier K(+) channel Kir3.3; DE AltName: Full=Potassium channel, inwardly rectifying subfamily J member 9; GN Name=KCNJ9; Synonyms=GIRK3; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT VAL-366. RX PubMed=10659995; DOI=10.1016/s0898-6568(99)00059-5; RA Schoots O., Wilson J.M., Ethier N., Bigras E., Hebert T.E., Van Tol H.H.M.; RT "Co-expression of human Kir3 subunits can yield channels with different RT functional properties."; RL Cell. Signal. 11:871-883(1999). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT VAL-366. RX PubMed=10913335; DOI=10.1006/bbrc.2000.3136; RA Vaughn J., Wolford J.K., Prochazka M., Permana P.A.; RT "Genomic structure and expression of human KCNJ9 (Kir3.3/GIRK3)."; RL Biochem. Biophys. Res. Commun. 274:302-309(2000). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16710414; DOI=10.1038/nature04727; RA Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., RA Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., RA Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K., RA Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C., RA Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W., RA Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J., RA Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., RA Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., RA Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., RA Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H., RA Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L., RA Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J., RA Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S., RA Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K., RA Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R., RA Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M., RA Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S., RA Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J., RA Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., RA McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N., RA Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V., RA Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J., RA Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E., RA Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S., RA Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M., RA White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H., RA Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E., RA Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G., RA Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.; RT "The DNA sequence and biological annotation of human chromosome 1."; RL Nature 441:315-321(2006). CC -!- FUNCTION: This receptor is controlled by G proteins. Inward rectifier CC potassium channels are characterized by a greater tendency to allow CC potassium to flow into the cell rather than out of it. Their voltage CC dependence is regulated by the concentration of extracellular CC potassium; as external potassium is raised, the voltage range of the CC channel opening shifts to more positive voltages. The inward CC rectification is mainly due to the blockage of outward current by CC internal magnesium (By similarity). {ECO:0000250}. CC -!- SUBUNIT: Associates with GIRK1 to form a G-protein-activated CC heteromultimer pore-forming unit. Interacts (via PDZ-binding motif) CC with SNX27 (via PDZ domain); the interaction is required when CC endocytosed to prevent degradation in lysosomes and promote recycling CC to the plasma membrane (By similarity). {ECO:0000250}. CC -!- INTERACTION: CC Q92806; Q5SNT2-2: TMEM201; NbExp=3; IntAct=EBI-12822837, EBI-11994282; CC -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein. CC -!- DOMAIN: The PDZ-binding motif specifically binds the PDZ domain of CC SNX27: the specificity for SNX27 is provided by the 2 residues located CC upstream (Glu-388 and Ser-389) of the PDZ-binding motif. {ECO:0000250}. CC -!- SIMILARITY: Belongs to the inward rectifier-type potassium channel CC (TC 1.A.2.1) family. KCNJ9 subfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; U52152; AAB07043.1; -; mRNA. DR EMBL; AF193615; AAF89098.1; -; Genomic_DNA. DR EMBL; AL121987; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR CCDS; CCDS1194.1; -. DR RefSeq; NP_004974.2; NM_004983.2. DR PDB; 6X23; X-ray; 2.15 A; B=384-393. DR PDBsum; 6X23; -. DR AlphaFoldDB; Q92806; -. DR SMR; Q92806; -. DR BioGRID; 109967; 4. DR IntAct; Q92806; 1. DR STRING; 9606.ENSP00000357067; -. DR ChEMBL; CHEMBL3038490; -. DR DrugBank; DB00898; Ethanol. DR DrugBank; DB11633; Isavuconazole. DR TCDB; 1.A.2.1.19; the inward rectifier k(+) channel (irk-c) family. DR iPTMnet; Q92806; -. DR PhosphoSitePlus; Q92806; -. DR BioMuta; KCNJ9; -. DR DMDM; 125987834; -. DR jPOST; Q92806; -. DR MassIVE; Q92806; -. DR PaxDb; 9606-ENSP00000357067; -. DR PeptideAtlas; Q92806; -. DR ProteomicsDB; 75491; -. DR ABCD; Q92806; 1 sequenced antibody. DR Antibodypedia; 34266; 151 antibodies from 29 providers. DR DNASU; 3765; -. DR Ensembl; ENST00000368088.4; ENSP00000357067.3; ENSG00000162728.5. DR GeneID; 3765; -. DR KEGG; hsa:3765; -. DR MANE-Select; ENST00000368088.4; ENSP00000357067.3; NM_004983.3; NP_004974.2. DR UCSC; uc001fuy.2; human. DR AGR; HGNC:6270; -. DR CTD; 3765; -. DR DisGeNET; 3765; -. DR GeneCards; KCNJ9; -. DR HGNC; HGNC:6270; KCNJ9. DR HPA; ENSG00000162728; Tissue enriched (brain). DR MIM; 600932; gene. DR neXtProt; NX_Q92806; -. DR OpenTargets; ENSG00000162728; -. DR PharmGKB; PA30051; -. DR VEuPathDB; HostDB:ENSG00000162728; -. DR eggNOG; KOG3827; Eukaryota. DR GeneTree; ENSGT01080000257365; -. DR HOGENOM; CLU_022738_11_0_1; -. DR InParanoid; Q92806; -. DR OMA; RFSPMML; -. DR OrthoDB; 4126787at2759; -. DR PhylomeDB; Q92806; -. DR TreeFam; TF313676; -. DR PathwayCommons; Q92806; -. DR Reactome; R-HSA-1296041; Activation of G protein gated Potassium channels. DR Reactome; R-HSA-997272; Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits. DR SignaLink; Q92806; -. DR BioGRID-ORCS; 3765; 90 hits in 1137 CRISPR screens. DR GeneWiki; KCNJ9; -. DR GenomeRNAi; 3765; -. DR Pharos; Q92806; Tbio. DR PRO; PR:Q92806; -. DR Proteomes; UP000005640; Chromosome 1. DR RNAct; Q92806; Protein. DR Bgee; ENSG00000162728; Expressed in middle temporal gyrus and 88 other cell types or tissues. DR GO; GO:0034702; C:monoatomic ion channel complex; IEA:UniProtKB-KW. DR GO; GO:0098688; C:parallel fiber to Purkinje cell synapse; IEA:Ensembl. DR GO; GO:0005886; C:plasma membrane; IBA:GO_Central. DR GO; GO:0042734; C:presynaptic membrane; IEA:Ensembl. DR GO; GO:0015467; F:G-protein activated inward rectifier potassium channel activity; IEA:InterPro. DR GO; GO:0005242; F:inward rectifier potassium channel activity; IBA:GO_Central. DR GO; GO:1990573; P:potassium ion import across plasma membrane; IBA:GO_Central. DR GO; GO:0034765; P:regulation of monoatomic ion transmembrane transport; IBA:GO_Central. DR GO; GO:0099505; P:regulation of presynaptic membrane potential; IEA:Ensembl. DR Gene3D; 1.10.287.70; -; 1. DR Gene3D; 2.60.40.1400; G protein-activated inward rectifier potassium channel 1; 1. DR InterPro; IPR014756; Ig_E-set. DR InterPro; IPR041647; IRK_C. DR InterPro; IPR016449; K_chnl_inward-rec_Kir. DR InterPro; IPR003276; K_chnl_inward-rec_Kir3.3. DR InterPro; IPR013518; K_chnl_inward-rec_Kir_cyto. DR InterPro; IPR040445; Kir_TM. DR PANTHER; PTHR11767:SF17; G PROTEIN-ACTIVATED INWARD RECTIFIER POTASSIUM CHANNEL 3; 1. DR PANTHER; PTHR11767; INWARD RECTIFIER POTASSIUM CHANNEL; 1. DR Pfam; PF01007; IRK; 1. DR Pfam; PF17655; IRK_C; 1. DR PIRSF; PIRSF005465; GIRK_kir; 1. DR PRINTS; PR01329; KIR33CHANNEL. DR PRINTS; PR01320; KIRCHANNEL. DR SUPFAM; SSF81296; E set domains; 1. DR SUPFAM; SSF81324; Voltage-gated potassium channels; 1. DR Genevisible; Q92806; HS. PE 1: Evidence at protein level; KW 3D-structure; Ion channel; Ion transport; Membrane; Potassium; KW Potassium transport; Reference proteome; Transmembrane; KW Transmembrane helix; Transport; Voltage-gated channel. FT CHAIN 1..393 FT /note="G protein-activated inward rectifier potassium FT channel 3" FT /id="PRO_0000154950" FT TOPO_DOM 1..57 FT /note="Cytoplasmic" FT /evidence="ECO:0000250" FT TRANSMEM 58..82 FT /note="Helical; Name=M1" FT /evidence="ECO:0000250" FT TOPO_DOM 83..106 FT /note="Extracellular" FT /evidence="ECO:0000250" FT INTRAMEM 107..118 FT /note="Helical; Pore-forming; Name=H5" FT /evidence="ECO:0000250" FT INTRAMEM 119..125 FT /note="Pore-forming" FT /evidence="ECO:0000250" FT TOPO_DOM 126..134 FT /note="Extracellular" FT /evidence="ECO:0000250" FT TRANSMEM 135..156 FT /note="Helical; Name=M2" FT /evidence="ECO:0000250" FT TOPO_DOM 157..393 FT /note="Cytoplasmic" FT /evidence="ECO:0000250" FT REGION 1..23 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 360..393 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOTIF 120..125 FT /note="Selectivity filter" FT /evidence="ECO:0000250" FT MOTIF 390..393 FT /note="PDZ-binding" FT SITE 150 FT /note="Role in the control of polyamine-mediated channel FT gating and in the blocking by intracellular magnesium" FT /evidence="ECO:0000250" FT VARIANT 366 FT /note="A -> V (in dbSNP:rs3001040)" FT /evidence="ECO:0000269|PubMed:10659995, FT ECO:0000269|PubMed:10913335" FT /id="VAR_023568" FT STRAND 389..392 FT /evidence="ECO:0007829|PDB:6X23" SQ SEQUENCE 393 AA; 44020 MW; C6F79F80A37B01C9 CRC64; MAQENAAFSP GQEEPPRRRG RQRYVEKDGR CNVQQGNVRE TYRYLTDLFT TLVDLQWRLS LLFFVLAYAL TWLFFGAIWW LIAYGRGDLE HLEDTAWTPC VNNLNGFVAA FLFSIETETT IGYGHRVITD QCPEGIVLLL LQAILGSMVN AFMVGCMFVK ISQPNKRAAT LVFSSHAVVS LRDGRLCLMF RVGDLRSSHI VEASIRAKLI RSRQTLEGEF IPLHQTDLSV GFDTGDDRLF LVSPLVISHE IDAASPFWEA SRRALERDDF EIVVILEGMV EATGMTCQAR SSYLVDEVLW GHRFTSVLTL EDGFYEVDYA SFHETFEVPT PSCSARELAE AAARLDAHLY WSIPSRLDEK VEEEGAGEGA GGEAGADKEQ NGCLPPPESE SKV //